×
More Charts Below
Sol-Gel Technologies Pre-Tax Income 2016-2024 | SLGL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Recent Trends
Sol-Gel Technologies pre-tax income from 2016 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$15.5B
Dr Reddy's Laboratories (RDY)
$11.4B
BridgeBio Pharma (BBIO)
$6.4B
Bausch Health Cos (BHC)
$1.9B
Supernus Pharmaceuticals (SUPN)
$1.7B
Amphastar Pharmaceuticals (AMPH)
$1.1B
Personalis (PSNL)
$282M
Taysha Gene Therapies (TSHA)
$254M
Assembly Biosciences (ASMB)
$75M
Evoke Pharma (EVOK)
$3M
Teligent (TLGT)
$0M